항광견병 혈청 시장 보고서(2026년)

Anti-rabies serum, also known as rabies immune globulin (RIG), is a medical treatment used to provide immediate passive immunity against the rabies virus. It is typically administered to individuals who have been exposed to the virus through bites or scratches from potentially rabid animals, often alongside the rabies vaccine. The serum contains antibodies that neutralize the virus, helping to prevent the onset of rabies, which can be fatal once symptoms appear.

The main types of anti-rabies serum include human anti-rabies immunoglobulin and equine anti-rabies immunoglobulin. Human rabies immune globulin (HRIG) is derived from the blood plasma of human donors who have been immunized against rabies. It is preferred due to its reduced risk of allergic reactions and better compatibility with human patients. These serums are available in various dosage forms, including vials and prefilled syringes, and are administered via intravenous or intramuscular routes. They are used by a wide range of end-users, including hospitals, clinics, and veterinary hospitals.

Tariffs are impacting the anti-rabies serum market by increasing costs of imported plasma-derived raw materials, biologics processing equipment, sterile packaging components, and cold-chain logistics systems used in immunoglobulin production and distribution. Hospitals and public health agencies in Asia-Pacific, Africa, and Latin America are most affected due to reliance on imported serums and limited domestic manufacturing capacity. These tariffs are increasing procurement costs and placing pressure on public healthcare budgets. However, they are also encouraging local plasma collection programs, regional biologics manufacturing investments, and improved supply chain resilience for essential rabies treatments.

The anti-rabies serum market research report is one of a series of new reports from The Business Research Company that provides anti-rabies serum market statistics, including anti-rabies serum industry global market size, regional shares, competitors with a anti-rabies serum market share, detailed anti-rabies serum market segments, market trends and opportunities, and any further data you may need to thrive in the anti-rabies serum industry. This anti-rabies serum market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti-rabies serum market size has grown strongly in recent years. It will grow from $1.5 billion in 2025 to $1.58 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increasing incidence of rabies exposure cases, expansion of hospital-based emergency treatment protocols, availability of equine-derived immunoglobulins, government-supported rabies control programs, rising awareness of post-exposure prophylaxis.

The anti-rabies serum market size is expected to see strong growth in the next few years. It will grow to $1.95 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to increasing adoption of human anti-rabies immunoglobulin, expansion of rabies prevention initiatives in developing regions, rising investments in biologics manufacturing, growing focus on safer serum alternatives, strengthening public health vaccination frameworks. Major trends in the forecast period include increasing adoption of human-derived immunoglobulins, rising preference for prefilled syringe formats, expansion of cold-chain optimized serum distribution, growing focus on high-purity antibody formulations, improved standardization of post-exposure prophylaxis protocols.

The rising prevalence of dog bites is expected to drive the growth of the anti-rabies serum market. Dog bites refer to injuries caused when a dog bites or scratches a person, with severity ranging from minor to severe. These bites can lead to infections, significant wounds, and in some cases, the transmission of diseases such as rabies. Effective prevention and prompt medical treatment are crucial to managing the risks associated with dog bites. Factors such as increased urbanization, leading to more frequent interactions between people and dogs, a higher number of unrestrained or poorly trained dogs, and insufficient awareness about dog behavior and bite prevention, are contributing to the rising prevalence of dog bites. This has resulted in an increased demand for anti-rabies serum, as timely administration of the serum is essential for preventing rabies in individuals exposed to potentially infected animals. For example, in 2023, according to the American Veterinary Medical Association, the average cost of dog bite insurance claims was $58,545, with insurers paying out $1.12 billion in liability claims related to dog bites and other dog-related injuries. Dog bite claims rose by nearly 10% in 2023. As such, the rising incidence of dog bites is driving growth in the anti-rabies serum market.

Leading companies in the anti-rabies serum market are forming strategic partnerships to enhance product development and expand their market reach. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefit. For example, in July 2023, Kedrion S.p.A., a US-based biopharmaceutical company, partnered with Kamada, an Israel-based biopharmaceutical company, to distribute KEDRAB (Rabies Immune Globulin [Human]) in the US. This collaboration has been key in co-developing and licensing the product while also raising awareness of rabies. The partnership helps protect individuals exposed to rabid animal bites from serious and potentially life-threatening conditions.

In December 2023, Kedrion Biopharma, an Italy-based biopharmaceutical company, signed a binding memorandum of understanding with Kamada Ltd. to extend and strengthen their collaboration for KEDRAB. This partnership aims to secure long-term supply, enhance commercial reach, and expand market opportunities in rabies prophylaxis. Kamada Ltd., based in Israel, specializes in plasma-derived protein therapeutics.

Major companies operating in the anti-rabies serum market are Merck & Co Inc., Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, HCX Pharmaceuticals LLP, Intas Pharmaceuticals Ltd, Bavarian Nordic AS, Serum Institute of India Pvt Ltd., Bharat Serums And Vaccines Limited, Indian Immunologicals Ltd., Bharat Biotech., National Institute of Health Islamabad, ViNS Bioproducts Ltd., Shanghai Serum Bio-technology, Premium Serums and Vaccines Pvt Ltd., Congruent Pharmachem, Haffkine Bio Pharmaceutical Corporation Limited, LEXICARE PHARMA PVT. LTD., Avin Darou, Central Research Institute Kasauli, Vigilomed Pharmaceuticals

North America was the largest region in the anti-rabies serum market in 2025. The regions covered in the anti-rabies serum market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anti-rabies serum market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anti-rabies serum market consists of sales of rabies monoclonal antibodies, rabies immune globulin (RIG) combination products, and human rabies immune globulin (HRIG). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anti-Rabies Serum Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses anti-rabies serum market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anti-rabies serum ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The anti-rabies serum market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Human Anti-rabies Immunoglobulin; Equine Anti-rabies Immunoglobulin
• 2) By Dosage And Form: Vials; Prefilled Syringes
• 3) By Route of Administration: Intravenous; Intramuscular
• 4) By End User: Hospitals; Clinics; Veterinary Hospitals
• Subsegments:
• 1) By Human Anti-Rabies Immunoglobulin: Monovalent Human Anti-Rabies Immunoglobulin; Polyvalent Human Anti-Rabies Immunoglobulin; Intramuscular Human Anti-Rabies Immunoglobulin; Intravenous Human Anti-Rabies Immunoglobulin; Freeze-Dried Human Anti-Rabies Immunoglobulin
• 2) By Equine Anti-Rabies Immunoglobulin: Freeze-Dried Equine Anti-Rabies Immunoglobulin; Liquid Equine Anti-Rabies Immunoglobulin; Monovalent Equine Anti-Rabies Immunoglobulin; Polyvalent Equine Anti-Rabies Immunoglobulin
• Companies Mentioned: Merck & Co Inc.; Sanofi SA; GlaxoSmithKline PLC; Takeda Pharmaceutical Company Limited; HCX Pharmaceuticals LLP; Intas Pharmaceuticals Ltd; Bavarian Nordic AS; Serum Institute of India Pvt Ltd.; Bharat Serums And Vaccines Limited; Indian Immunologicals Ltd.; Bharat Biotech.; National Institute of Health Islamabad; ViNS Bioproducts Ltd.; Shanghai Serum Bio-technology; Premium Serums and Vaccines Pvt Ltd.; Congruent Pharmachem; Haffkine Bio Pharmaceutical Corporation Limited; LEXICARE PHARMA PVT. LTD.; Avin Darou; Central Research Institute Kasauli; Vigilomed Pharmaceuticals
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Anti-Rabies Serum Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Anti-Rabies Serum Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Anti-Rabies Serum Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Anti-Rabies Serum Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Sustainability, Climate Tech & Circular Economy
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Human-Derived Immunoglobulins
  • 4.2.2 Rising Preference For Prefilled Syringe Formats
  • 4.2.3 Expansion Of Cold-Chain Optimized Serum Distribution
  • 4.2.4 Growing Focus On High-Purity Antibody Formulations
  • 4.2.5 Improved Standardization Of Post-Exposure Prophylaxis Protocols

5. Anti-Rabies Serum Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Emergency Care Centers
• 5.4 Public Health Agencies
• 5.5 Veterinary Hospitals

6. Anti-Rabies Serum Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Anti-Rabies Serum Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Anti-Rabies Serum PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Anti-Rabies Serum Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Anti-Rabies Serum Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Anti-Rabies Serum Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Anti-Rabies Serum Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Anti-Rabies Serum Market Segmentation

• 9.1. Global Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin
• 9.2. Global Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Vials, Prefilled Syringes
• 9.3. Global Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Intravenous, Intramuscular
• 9.4. Global Anti-Rabies Serum Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinics, Veterinary Hospitals
• 9.5. Global Anti-Rabies Serum Market, Sub-Segmentation Of Human Anti-Rabies Immunoglobulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Monovalent Human Anti-Rabies Immunoglobulin, Polyvalent Human Anti-Rabies Immunoglobulin, Intramuscular Human Anti-Rabies Immunoglobulin, Intravenous Human Anti-Rabies Immunoglobulin, Freeze-Dried Human Anti-Rabies Immunoglobulin
• 9.6. Global Anti-Rabies Serum Market, Sub-Segmentation Of Equine Anti-Rabies Immunoglobulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Freeze-Dried Equine Anti-Rabies Immunoglobulin, Liquid Equine Anti-Rabies Immunoglobulin, Monovalent Equine Anti-Rabies Immunoglobulin, Polyvalent Equine Anti-Rabies Immunoglobulin

10. Anti-Rabies Serum Market Regional And Country Analysis

• 10.1. Global Anti-Rabies Serum Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Anti-Rabies Serum Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Anti-Rabies Serum Market

• 11.1. Asia-Pacific Anti-Rabies Serum Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Anti-Rabies Serum Market

• 12.1. China Anti-Rabies Serum Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Anti-Rabies Serum Market

• 13.1. India Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Anti-Rabies Serum Market

• 14.1. Japan Anti-Rabies Serum Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Anti-Rabies Serum Market

• 15.1. Australia Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Anti-Rabies Serum Market

• 16.1. Indonesia Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Anti-Rabies Serum Market

• 17.1. South Korea Anti-Rabies Serum Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Anti-Rabies Serum Market

• 18.1. Taiwan Anti-Rabies Serum Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Anti-Rabies Serum Market

• 19.1. South East Asia Anti-Rabies Serum Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Anti-Rabies Serum Market

• 20.1. Western Europe Anti-Rabies Serum Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Anti-Rabies Serum Market

• 21.1. UK Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Anti-Rabies Serum Market

• 22.1. Germany Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Anti-Rabies Serum Market

• 23.1. France Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Anti-Rabies Serum Market

• 24.1. Italy Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Anti-Rabies Serum Market

• 25.1. Spain Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Anti-Rabies Serum Market

• 26.1. Eastern Europe Anti-Rabies Serum Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Anti-Rabies Serum Market

• 27.1. Russia Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Anti-Rabies Serum Market

• 28.1. North America Anti-Rabies Serum Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Anti-Rabies Serum Market

• 29.1. USA Anti-Rabies Serum Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Anti-Rabies Serum Market

• 30.1. Canada Anti-Rabies Serum Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Anti-Rabies Serum Market

• 31.1. South America Anti-Rabies Serum Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Anti-Rabies Serum Market

• 32.1. Brazil Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Anti-Rabies Serum Market

• 33.1. Middle East Anti-Rabies Serum Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Anti-Rabies Serum Market

• 34.1. Africa Anti-Rabies Serum Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Anti-Rabies Serum Market, Segmentation By Type, Segmentation By Dosage And Form, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Anti-Rabies Serum Market Regulatory and Investment Landscape

36. Anti-Rabies Serum Market Competitive Landscape And Company Profiles

• 36.1. Anti-Rabies Serum Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Anti-Rabies Serum Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Anti-Rabies Serum Market Company Profiles
  • 36.3.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. HCX Pharmaceuticals LLP Overview, Products and Services, Strategy and Financial Analysis

37. Anti-Rabies Serum Market Other Major And Innovative Companies

• Intas Pharmaceuticals Ltd, Bavarian Nordic AS, Serum Institute of India Pvt Ltd., Bharat Serums And Vaccines Limited, Indian Immunologicals Ltd., Bharat Biotech., National Institute of Health Islamabad, ViNS Bioproducts Ltd., Shanghai Serum Bio-technology, Premium Serums and Vaccines Pvt Ltd., Congruent Pharmachem, Haffkine Bio Pharmaceutical Corporation Limited, LEXICARE PHARMA PVT. LTD., Avin Darou, Central Research Institute Kasauli

38. Global Anti-Rabies Serum Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Anti-Rabies Serum Market

40. Anti-Rabies Serum Market High Potential Countries, Segments and Strategies

• 40.1 Anti-Rabies Serum Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Anti-Rabies Serum Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Anti-Rabies Serum Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer